BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32185277)

  • 1. Study of the natural course and specific immunity after herpes zoster in patients with rheumatoid arthritis receiving biologic DMARDs.
    Thomas K; Sfikakis PP; Boumpas D; Boki K; Vassilopoulos D
    Mediterr J Rheumatol; 2017 Sep; 28(3):164-168. PubMed ID: 32185277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis.
    Krasselt M; Baerwald C; Liebert UG; Seifert O
    Clin Rheumatol; 2019 Sep; 38(9):2493-2500. PubMed ID: 31028550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs.
    Schub D; Assmann G; Sester U; Sester M; Schmidt T
    Arthritis Res Ther; 2018 Nov; 20(1):252. PubMed ID: 30413189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.
    Kojima S; Iwamoto T; Kobayashi Y; Kato M; Takizawa F; Ida T; Suzuki J; Toda Y; Miyachi K; Iwata A; Furuta S; Ikeda K; Nakajima H
    RMD Open; 2024 Feb; 10(1):. PubMed ID: 38388170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study.
    Venerito V; Stefanizzi P; Cantarini L; Lavista M; Galeone MG; Di Lorenzo A; Iannone F; Tafuri S; Lopalco G
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral Immunity to Varicella Zoster Virus in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Compared to Healthy Controls.
    Krasselt M; Baerwald C; Liebert UG; Seifert O
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33915820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.
    Park HB; Kim KC; Park JH; Kang TY; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Craft J; Jung S
    J Rheumatol; 2004 Nov; 31(11):2151-5. PubMed ID: 15517626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis.
    Rondaan C; van der Geest KSM; Eelsing E; Boots AMH; Bos NA; Westra J; Brouwer E
    Front Immunol; 2017; 8():1377. PubMed ID: 29118757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, and Humoral and Cell-mediated Immune Responses to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis.
    Koh JH; Lee J; Kim SH; Kwok SK; Ju JH; Park SH
    J Rheumatol; 2018 Apr; 45(4):465-469. PubMed ID: 29419465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
    Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
    Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
    Liao TL; Chen YM; Liu HJ; Chen DY
    BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4
    Haredy AM; Takei M; Iwamoto SI; Ohno M; Kosaka M; Hirota K; Koketsu R; Okuno T; Ikuta K; Yamanishi K; Ebina H
    Vaccine; 2019 Aug; 37(36):5225-5232. PubMed ID: 31358406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice.
    Wui SR; Kim KS; Ryu JI; Ko A; Do HTT; Lee YJ; Kim HJ; Lim SJ; Park SA; Cho YJ; Kim CG; Lee NG
    Vaccine; 2019 Apr; 37(15):2131-2141. PubMed ID: 30827737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.
    Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
    Arthritis Rheum; 2007 Dec; 57(8):1431-8. PubMed ID: 18050184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital Herpes Zoster as Possible Indicator of HIV Infection.
    Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Chosen Cytokine Levels among Patients with Herpes Zoster as Ability to Provide Immune Response.
    Zajkowska A; Garkowski A; Świerzbińska R; Kułakowska A; Król ME; Ptaszyńska-Sarosiek I; Nowicka-Ciełuszecka A; Pancewicz S; Czupryna P; Moniuszko A; Zajkowska J
    PLoS One; 2016; 11(3):e0150301. PubMed ID: 26934574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era.
    Cacciapaglia F; Zuccaro C; Iannone F
    Clin Exp Rheumatol; 2015; 33(6):917-23. PubMed ID: 26394271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
    Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
    J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.